An excellent measured and I believe accurate assessment of the current situation by JP - I really rate this guy.
His assessment of the Culper report - "the report has zero credibility, the author has zero credibility". He was disappointed it has had as much airtime as it has in Australia.
In response to a question about the recent SP weakness for both ACAD and NEU, I think he was spot on in his assessment that the Culper report primed investor emotions to look for any perceived weaknesses (eg persistence) rather than see the overwhelming positive success of Daybue staring them in the face. He spent a bit of time talking about persistence and how it is tracking ahead of expectations and is baked into guidance.
Importantly, with all the Daybue hullabaloo since the Culper sham, he gave us a gentle reminder of something I have also posted about which is that the main game for NEU is NNZ-2591, not Daybue. He continues to have extremely high conviction in 2591 which gives me great comfort. Also mentioned they are considering further indications for it.
With all this Culper rubbish that has been going on and the SP gyrations it has caused, it's important to remember this about NEU -
NNZ-2591 = forest
Daybue sales = trees
- Forums
- ASX - By Stock
- NEU
- Ann: 2023 Results webinar
NEU
neuren pharmaceuticals limited
Add to My Watchlist
2.96%
!
$13.23

Ann: 2023 Results webinar, page-11
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$13.23 |
Change
0.380(2.96%) |
Mkt cap ! $1.652B |
Open | High | Low | Value | Volume |
$13.15 | $13.37 | $12.92 | $4.258M | 324.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
5 | 83 | $13.22 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$13.24 | 120 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
11 | 313 | 13.230 |
6 | 550 | 13.220 |
16 | 3126 | 13.210 |
8 | 1680 | 13.200 |
4 | 1270 | 13.190 |
Price($) | Vol. | No. |
---|---|---|
13.250 | 115 | 5 |
13.260 | 867 | 11 |
13.270 | 1648 | 10 |
13.280 | 1495 | 8 |
13.290 | 2261 | 6 |
Last trade - 12.17pm 18/06/2025 (20 minute delay) ? |
Featured News
NEU (ASX) Chart |
The Watchlist
MEM
MEMPHASYS LIMITED.
Professor John Aitken, Scientific Director
Professor John Aitken
Scientific Director
Previous Video
Next Video
SPONSORED BY The Market Online